Deferoxamine
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-B1625-1MG | 1 mg | 115,00 | Add | |
| HY-B1625-5MG | 5 mg | 283,00 | Add | |
| HY-B1625-10MG | 10 mg | 451,00 | Add |
* CHF, excl. 7.7% VAT and shipping costs
Product Description
35% discount on MedChem product orders above CHF 1'000 !
Conditions:
- 1st November - 31st December 2023
- Not cumulative with the "30% off Screening Libraries Promotion"
Deferoxamine B; Deferriferrioxamine B; Deferrioxamine
Deferoxamine (Deferoxamine B) is an iron chelator (binds to Fe(III) and many other metal cations), is widely used to reduce iron accumulation and deposition in tissues. Deferoxamine upregulates HIF-1α levels with good antioxidant activity. Deferoxamine also shows anti-proliferative activity, can induce apoptosis and autophagy in cancer cells. Deferoxamine can be used in studies of diabetes, neurodegenerative diseases as well as anti-cancer and anti-COVID-19[1][2][3][4][5].
| Category | Biochemicals |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Cancer, Infection, Metabolic Disease, Inflammation/Immunology, Neurological Disease, Apoptosis,Autophagy,Immunology/Inflammation,Metabolic Enzyme/Protease,NF-κB,PI3K/Akt/mTOR |
| Format | Solubility: 10 mM in DMSO |
| Grade | Clinical information: Launched |
| Purity | 98% |
| Molecular Formula | C25H48N6O8 |
| Molecular Weight | 560.68 |
| CAS-Number | 70-51-9 |
| Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
